How could you utilize neuromuscular ultrasound as a marker of disease progression/treatment response in CIDP?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

When do you consider sciatic nerve imaging in cases of foot drop without clinical or EMG involvement beyond the peroneal nerve without clearly indentified compression site?

How long can demyelinating findings persist on nerve conduction studies (NCS) after AIDP illness?

In an ALS patient with FVC 60–70% predicted, normal daytime ABG, and normal nocturnal oximetry, but persistent orthopnea and unrefreshing sleep, do you initiate nocturnal NIV — and if so, how do you navigate the CMS coverage gap?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.